AI in Cancer Immunotherapy
07
Aug
-
08
Aug
2023
When
Boston

USA
Where

Great progress has been made in studying cancer immunology and the development of immunotherapies. The complexity of the immune system and the duplicity of cancer, plus the expense of treatments and variable patient responses, make for a perfect data storm. Artificial intelligence (AI), machine learning (ML), deep learning (DL), and artificial neural networks (ANN) are poised to help unlock cancer’s secrets, identify, and validate immuno-oncology (IO) targets, evaluate assets, and apply effective immunotherapies. However, optimally utilizing and effectively mining these large diverse data sets is daunting. The combined efforts of researchers, clinicians, and data scientists are required. Join colleagues to share strategies and celebrate successes at CHI’s Inaugural AI in Cancer Immunotherapy meeting.

Similar Events

You May Like

Event

Cambridge Healthtech Institute

0/5
(0)

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

07 - 08 Aug 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

SVP, Head of Clinical
President, Head of Research and Development
Department of Pathology
Executive Director, Conferences
Principal Scientist
Assistant Professor
Vice President
Chief Information Officer
Endowed Florida Department of Health Cancer Chair
Postdoctoral Researcher
Executive Director - Data Science

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Charles River Laboratories

At Charles River, we are passionate about our role in improving the quality of people’s lives.

Biocytogen

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

FUJIFILM Pharmaceuticals U.S.A., Inc.

Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug development.

Sanyou Biopharmaceuticals Co., Ltd.

Sanyou Biopharmaceuticals Co., Ltd. is a leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs.

Genscript Probio

The CDMO segment of the world's leading biotech company GenScript.

Telesis Bio

Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges.

OmniAb, Inc.

The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Selvita

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

Nona Biosciences

Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal

BostonGene

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in

NeoSome Life Sciences

NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, O

Organizer

Get emails from us

Thank you
Oops! Something went wrong